GMO Salmon was approved for human consumption last fall via a New Animal Drug Application. This panel will explore the controversial nature of this approval as well as its wider implication for animal and human food and drugs.

• Review and analysis of the approval process for transgenic animals through use of a NADA
• understanding why a potential food is approved as an animal drug
• Glofish exemption v. AquAdvantage NADA Approval
• differences and controversies
• Implications for what new animal drug approval for transgenic animals such as AquAdvantage salmon will have on animal and human foods chain
• Exploring the labeling controversy for AquAdvantage salmon and other GMO foods in both the animal and human food industries